NDRA — ENDRA Life Sciences Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1681682 ·
Last close
$5.20
Market Cap
$6.60M
52W High
$6.69
52W Low
$2.96
ADV30
17,588
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,173,748 | -1,311,433 | 3,438,182 | 356,462 | 1,651,297 |
| Dec 2025 | 0 | — | -1,622,026 | -3,169,209 | 3,853,797 | 762,365 | 1,593,677 |
| Sep 2025 | 0 | — | -1,370,703 | -1,595,959 | 1,964,108 | 794,036 | 1,792,728 |
| Jun 2025 | 0 | — | -1,301,090 | -1,225,912 | 2,807,672 | 1,808,574 | 1,334,521 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,182,558
Investing CF
$-3,017,280
Financing CF
$5,732,723
CapEx
$-3,017,280
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-14.65
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-110,465,509
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-5,763,101
Pretax Income TTM
$-7,027,410
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -5,763,101 | -7,027,410 | 3,853,797 | 1,593,677 | — | -5,182,558 |
| Dec 2024 | 0 | -10,817,147 | -11,507,947 | 4,452,362 | 1,891,996 | — | -7,400,547 |
| Dec 2023 | 0 | -10,520,735 | -10,060,250 | 6,754,146 | 1,095,157 | — | -9,548,775 |
| Dec 2022 | 0 | -13,157,559 | -13,179,092 | 9,274,147 | 2,069,643 | — | -12,769,371 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-4.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $6.34M | $2.65 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $6.33M | $7.40 | — |
| RBOT | Vicarious Surgical Inc. | $6.21M | $0.96 | — |
| HSCS | HeartSciences Inc. | $6.15M | $1.93 | — |
| STME | Stimcell Energetics Inc. | $6.13M | $0.29 | — |
News headlines (Yahoo Finance, 1h cache)
ENDRA Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
2026-05-18 12:00 · Yahoo
ENDRA Life Sciences Reports Multi-Site Validation of TAEUS® Liver Device Demonstrating MRI-like Accuracy and Reproducibility
2026-05-14 12:00 · Yahoo
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
2026-03-31 20:05 · Yahoo
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
2026-03-25 12:00 · Yahoo
NDRA's TAEUS Device Achieves MRI-Level Liver Imaging Precision
2026-03-03 15:15 · Yahoo
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
2026-02-26 13:00 · Yahoo
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
2025-12-04 13:00 · Yahoo
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
2025-11-20 13:00 · Yahoo
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
2025-11-17 13:00 · Yahoo
Endra Life Sciences commences staking of HYPE digital asset holdings
2025-11-14 14:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.